» Articles » PMID: 26647307

ACTG2 Variants Impair Actin Polymerization in Sporadic Megacystis Microcolon Intestinal Hypoperistalsis Syndrome

Abstract

Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (MMIHS) is a rare congenital disorder, in which heterozygous missense variants in the Enteric Smooth Muscle actin γ-2 (ACTG2) gene have been recently identified. To investigate the mechanism by which ACTG2 variants lead to MMIHS, we screened a cohort of eleven MMIHS patients, eight sporadic and three familial cases, and performed immunohistochemistry, molecular modeling and molecular dynamics (MD) simulations, and in vitro assays. In all sporadic cases, a heterozygous missense variant in ACTG2 was identified. ACTG2 expression was detected in all intestinal layers where smooth muscle cells are present in different stages of human development. No histopathological abnormalities were found in the patients. Using molecular modeling and MD simulations, we predicted that ACTG2 variants lead to significant changes to the protein function. This was confirmed by in vitro studies, which showed that the identified variants not only impair ACTG2 polymerization, but also contribute to reduced cell contractility. Taken together, our results confirm the involvement of ACTG2 in sporadic MMIHS, and bring new insights to MMIHS pathogenesis.

Citing Articles

Modified Martin Procedure for Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (MMIHS).

Tian L, Ma C, Cao P, Yu D Indian J Pediatr. 2025; .

PMID: 39951033 DOI: 10.1007/s12098-024-05404-7.


Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy.

Ceron R, Baez-Cruz F, Palmer N, Carman P, Boczkowska M, Heuckeroth R Sci Adv. 2024; 10(22):eadn6615.

PMID: 38820162 PMC: 11141634. DOI: 10.1126/sciadv.adn6615.


Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS): challenges in diagnosis and management.

Murali K, Dhua A BMJ Case Rep. 2024; 17(4).

PMID: 38627049 PMC: 11029411. DOI: 10.1136/bcr-2024-259983.


Genome-wide analysis identifies MYH11 compound heterozygous variants leading to visceral myopathy corresponding to late-onset form of megacystis-microcolon-intestinal hypoperistalsis syndrome.

Billon C, Piccoli G, de Sainte Agathe J, Stoeva R, Derive N, Heidet L Mol Genet Genomics. 2024; 299(1):44.

PMID: 38625590 DOI: 10.1007/s00438-024-02136-3.


Exploring the complexities of megacystis-microcolon-intestinal hypoperistalsis syndrome: insights from genetic studies.

Devavarapu P, Uppaluri K, Nikhade V, Palasamudram K, Sri Manjari K Clin J Gastroenterol. 2024; 17(3):383-395.

PMID: 38461165 DOI: 10.1007/s12328-024-01934-x.